Daniel Martin

Dr. Daniel Martin

orcid

Biography

My work focuses on a suite of novel mass-spectrometry techniques, collectively known as N-terminomics, that includes using terminal amine isotope labeling of substrates (TAILS). TAILS utilizes isotopic and isobaric labeling to enrich the N-termini of proteolytic products and provides expanded degradomic information and increased proteomic coverage. Using this technical strategy, I have identified substrates for proteases involved in both congenital human diseases including the ciliopathies nephronophthisis and Joubert syndrome (ADAMTS1/5/9 substrates), Marfan syndrome and related connective tissue diseases (ADAMTS6 substrates), and aging-related diseases such aortic aneurysm and osteoarthritis (mast cell chymase/CMA1 substrates). I have also applied N-terminomics to define the landscape of proteolytic remodeling in human thoracic aortic aneurysms, infective endocarditis, a mouse model of heart failure, and other biological/disease contexts using human tissue, mouse models, and cell culture.

Affiliations

No affiliation has been shared yet.

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.